AMLX — Amylyx Pharmaceuticals Share News
0.000.00%
Last trade - 00:00Amylyx Pharmaceuticals Inc expected to post a loss of 1 cent a share - Earnings Preview
Brief: Amylyx Pharmaceuticals Announces Interim Data From Ongoing Mid-Stage Trial Of AMX0035
U.S. STOCKS ON THE MOVE-US banks, Hertz, Spirit,
U.S. STOCKS ON THE MOVE-Delta Air Lines, Alternus Clean Energy, US banks
U.S. STOCKS ON THE MOVE-Meta, Intuitive Machines, Conagra Brands
Amylyx Pharmaceuticals rises on job cuts
Amylyx Pharma to remove ALS drug from US, Canada markets (updated)
Brief: Amylyx Pharmaceuticals Expects To Incur Severance-Related Charges Of About $19 Million
Brief: Amylyx Pharmaceuticals Announces Formal Intention To Remove Relyvrio®/Albrioza™ From The Market
Amylyx Pharmaceuticals to remove ALS drug from US, Canada markets
U.S. STOCKS ON THE MOVE-Rumble, Geron, Gold miners
U.S. STOCKS ON THE MOVE-Li-Cycle Holdings, Priority Technology, 3M
U.S. STOCKS ON THE MOVE-Madrigal Pharmaceuticals, Coinbase, Fractyl
Amylyx down after analysts downgrade stock post ALS drug's failure in crucial study
U.S. STOCKS ON THE MOVE-HCI Group, Cannabis firms, Costco Wholesale
U.S. STOCKS ON THE MOVE-HCI Group, Nvidia, BigBear.ai Holdings
Amylyx hits record low after approved ALS drug fails in confirmatory study
U.S. STOCKS ON THE MOVE-General Electric, Ainos, Velo3D
Amylyx's ALS drug fails in late-stage study, shares slump (updated)